Introduction

Naïve CD4
+ T cells can differentiate into diverse Th effector subsets upon activation in response to environment cues, often, cytokine milieu (25) (2, 34) . Antigen-dependent cytolytic activity of CD4 + T cells was initially observed in murine and human T cell clones and T cell lines in vitro (10, 13, 22, 23) . Subsequently,
CD4
+ T cells with cytotoxic potential were detected in both mice and humans with chronic viral infections such as HIV, CMV, EBV and LCMV infection as well as acute viral infections such as influenza virus (3, 7) . CD4 + T cells with cytotoxic potential express cytolytic molecules such as granzyme B (Gzmb) and perforin and can undergo granule exocytosis upon antigen stimulation.
Studies have established that the expression of these cytolytic molecules is crucial for the in vitro and in vivo killing activity of these CD4 + T cells (7, 9) .
Recent advances have also begun to uncover the function of CD4 + T cells with cytotoxic potential in
anti-viral and anti-tumor immunity in vivo (9, 23, 28) . In a mouse model of Ectromelia virus infection, CD4 + T cells with cytotoxic potential have been shown to directly control virus replication in a perforin-dependent manner, demonstrating the physiological role of these cells during a primary viral infection (9) . In a murine advanced model of melanoma, TCR-transgenic naive CD4 + T cells differentiated into Gzmb and perforin-expressing cells capable of lysing melanoma cells in vitro and in vivo, suggesting the potential of these cells for cancer immunotherapy (28) . Conversely, CD4 + T cells with cytotoxic potential may also exhibit adverse effects triggering autoimmunity and tissue injury. CD4 + T cells with cytotoxic potential have been detected in rheumatoid arthritis and ankylosing spondylitis and were able to mediate transplant rejection through a perforin-dependent mechanism (2, 14) . Thus, understanding the cellular and molecular mechanisms regulating the development of these cells is of considerable significance with respect to viral infections, cancer and auto-immunity. Currently, IL-2 signaling, low antigen dose, as well as OX40 and 41BB stimulation (6, 16, 29) (34) . CD4 + T cell clones derived from influenza-infected mice and the in vitro generated influenza-specific primary CD4 + T cells exhibited cytotoxic activity and were capable of protecting against lethal influenza infection (5, 13). More recently, it was demonstrated that CD4 + T cells isolated from influenza-infected lungs expressed Gzmb and perforin and were able to kill virusinfected cells through perforin-dependent mechanisms (7) . Furthermore, such perforin dependent cytotoxic mechanisms were able to place evolutionary pressure on the selection of epitope-specific influenza virus escape mutants (24) . Collectively, these data support the importance of CD4 + T cells with cytotoxic potential in promoting the clearance of influenza virus in vivo, and highlight the need to better understand the cellular and molecular mechanisms guiding the development of these T cells in vivo during influenza infection.
We have investigated the molecular cues in vivo governing the development of CD4 + T cells with cytotoxic potential during influenza infection. We found that the innate antiviral type I IFNs and the adaptive cytokine IL-2 coordinated the in vivo development of CD4 + T cells with cytotoxic potential. We further identified downstream signaling pathways and two transcription factors (T-bet and Blimp-1) controlling the development of these CD4 + T cells during influenza infection. Thus, we have begun to unravel the complex molecular network that controls the development of CD4 + T cells with cytotoxic potential during an acute viral infection.
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Materials and Methods
Mouse and infection. WT C57BL/6 mice were purchased from the Jackson Laboratory. T-bet- Iscove's media intranasally following anesthesia with ketamine and xylazine. In vivo IL-2 blockade was achieved through the injection of anti-IL-2 (clone: S4B6, Bio-X-Cell) at day 3 and day 5 p.i.
through i.p. (750 g/mouse/injection).
Quantitative RT-PCR. Lung single cell suspensions were prepared as previously described (32). In vitro DC/T cell co-culture. BMDC were generated as described (32). 
Chromatin immunoprecipitation (ChIP).
ChIP assay was performed as previously described (26) .
In brief, 6 x 10 6 cells were crosslinked for 10 min with 1% formaldehyde, lysed by sonication, and pre-cleared with salmon sperm DNA, bovine serum albumin, and Protein A agarose bead slurry (50%). Cell extracts were incubated with either rabbit polyclonal T-bet (4B10) or normal rabbit IgG 
Blimp-1 controls T-bet binding to cytolytic genes in CD4 + T cells
Blimp-1 is a transcriptional repressor and it is unclear how Blimp-1 positively controls Gzmb and perforin expression in T cells. We found that Blimp-1 deficiency enhanced T-bet expression in ChIP data are presented with the percentages of input as described in the Materials and Methods.
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